Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.7 USD | -0.42% | +10.59% | -4.28% |
Mar. 18 | Medical Properties Trust, Inc.(NYSE:MPW) added to S&P 600 | CI |
Mar. 18 | Medical Properties Trust, Inc.(NYSE:MPW) dropped from S&P 400 | CI |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The company's share price in relation to its net book value makes it look relatively cheap.
- This company will be of major interest to investors in search of a high dividend stock.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
- One of the major weak points of the company is its financial situation.
- Based on current prices, the company has particularly high valuation levels.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialized REITs
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-3.05% | 2.83B | C | ||
+3.68% | 52.79B | A- | ||
-12.22% | 17.56B | A- | ||
-5.40% | 12.99B | A | ||
-19.09% | 5.31B | B- | ||
+3.90% | 3.37B | C+ | ||
+9.25% | 3.27B | C- | ||
-10.60% | 2.89B | B+ | ||
+11.64% | 2.68B | C- | ||
-15.48% | 2.35B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock
- Equities
- Stock Medical Properties Trust, Inc. - Nyse
- Ratings Medical Properties Trust, Inc.